Şunu aradınız:: tlovr (İngilizce - Danca)

< 400 copies/ml (tlovr)
< 400 kopier/ml (tlovr)

itt-e population tlovr analysis
itt-e population tlovr analyse

itt (ext) population tlovr analysis
itt(ext) population tlovr analyse

imputations according to the tlovr algorithm
i henhold til tlovr-algoritmen (time to loss of viral response)

hiv-1 rna 400 copies/ml (tlovr)
hiv-1 rna 400 kopier/ml (tlovr)

tlovr = time to loss of virologic response a van elteren test
tlovr = time to loss of virologic response (tiden til ab af virologisk respons) a van elteren-test

a imputations according to the tlovr algorithm b last observation carried forward imputation
i henhold til locf (last obervation carried forward)

imputations according to the tlovr algorithm (tlovr = time to loss of virologic response)
imputeringer i henhold til tlovr- algoritmen (tlovr = tid til tab af virologisk respons).

imputations according to the tlovr algorithm b based on a normal approximation of the difference in% response c nc=f d difference in means
baseret på en normal approximation af forskellen i% respons c nc=f d forskelle i gennemsnit

efficacy outcome at week 48 in cna30021 by baseline hiv-1 rna and cd4 categories (itte tlovr art naïve subjects).
effektudbytte ved uge 48 i cna30021 ved baseline-hiv-1-rna og cd4-kategorier (itte tlovr art-naive patienter).

0.004** (4% to 22%)hiv-1 rna 50 copies/ml (tlovr) p-value
hiv-1 rna 50 kopier/ml (tlovr)

imputations according to the tlovr algorithm b based on normal approximation to the difference in% response c non-completer is failure imputation: patients who discontinued prematurely are imputed with a change equal to 0 d difference in means
baseret på en normal approximation af forskellen i% respons c patienter, der stoppede behandlingen for tidligt, tillægges en ændring lig 0 d forskelle i gennemsnit

in the time to loss of virological response (tlovr) analysis for the itt(e) population, the proportion of patients achieving < 400 copies/ ml was 73% (315 / 434) in the fosamprenavir with ritonavir group compared to 71% (317 / 444) of patients receiving lopinavir / ritonavir, with a 95% confidence interval of the difference of [-4,84%; 7; 05%].
ved tiden til tab af virologisk respons (tlovr) analyse af itt( e) gruppen, var andelen af patienter der opnåede < 400 kopier/ ml 73% (315/ 434) i fosamprenavir med ritonavir gruppen, sammenlignet med 71% (317/ 444) hos patienterne der modtog lopinavir/ ritonavir, med et 95% konfidensinterval med en forskel på [- 4, 84%; 7, 05%].